Latest News

Debate: Should Dermatologists or Rheumatologists Manage Musculoskeletal Symptoms in Patients With Psoriasis?


 

FROM GRAPPA 2024

Collaborative Care

During the follow-up discussion, both Dr. Proft and Dr. Savage agreed that dermatologists and rheumatologists should be working together in managing patients. “What we need to do is steer our patients toward collaborative care with our rheumatologists by trying to minimize delays to treatment, by working together in parallel clinics, combined clinics, and on virtual [multidisciplinary teams],” said Dr. Savage.

Dr. Proft agreed. “We should join forces and make decisions together.”

Dr. Savage and Dr. Proft did not provide any financial disclosures.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Lichenoid Dermatosis on the Feet
MDedge Dermatology
A 30-Year-Old White Female Presented With a 4-Month History of Scaly, Erythematous Patches and Plaques on Her Trunk and Extremities
MDedge Dermatology
Second Ustekinumab Biosimilar Gets FDA Approval
MDedge Dermatology
Combined Pediatric Derm-Rheum Clinics Supported by Survey Respondents
MDedge Dermatology
Positive Phase 2 Results Reported for TYK2 Inhibitor for Patients With Moderate to Severe Psoriasis
MDedge Dermatology
Specialists Are ‘Underwater’ With Some Insurance-Preferred Biosimilars
MDedge Dermatology
Recent Evidence for Home Phototherapy Benefits May Improve Access for Patients with Psoriasis
MDedge Dermatology
Study Finds Mace Risk Remains High in Patients with Psoriasis, Dyslipidemia
MDedge Dermatology
Need a Wood Lamp Alternative? Grab Your Smartphone
MDedge Dermatology
Pyzchiva Receives FDA Approval as Third Ustekinumab Biosimilar
MDedge Dermatology